# Drugmakers (domestic and overseas)

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/drugmakers-domestic-and-overseas
Canonical HTML page: https://gethealthbrief.com/entity/drugmakers-domestic-and-overseas

## Timeline

- **2026-12**: Expected Patient Access — Lower-priced drugs from the 12th round are targeted to reach patients by the end of 2026.
- **2026-07-31**: 12th Round Bidding and Results — The bidding takes place in Shanghai; preliminary results are released same evening showing 521 winning products from 327 companies for 65 drugs.
- **2018**: Program Launch — China initiates its first nationwide centralized drug procurement round to leverage volume-based purchasing for lower prices.

## Recent coverage (1 stories)

### China's 65-Drug Bulk Buy Aims to Cut Costs for 45,000 Hospitals by Year-End
2026-08-03 04:54:33 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

China’s 12th centralized drug procurement round selects 65 essential medicines, promising lower-cost access for patients at 45,000 medical institutions by late 2026. New quality rules tighten oversight, and the program now covers 555 drugs since 2018.
Full story: https://gethealthbrief.com/story/china-65-drug-bulk-procurement-healthcare-access-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.